New Vernon Capital Holdings II’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-1,601
Closed -$22.4K – 82
2023
Q4
$22.4K Sell
1,601
-25,537
-94% -$355K 0.01% 75
2023
Q3
$401K Buy
27,138
+1,020
+4% +$14.3K 0.35% 29
2023
Q2
$337K Buy
26,118
+4,331
+20% +$49.3K 0.23% 29
2023
Q1
$214K Buy
21,787
+169
+0.8% +$1.8K 0.16% 48
2022
Q4
$230K Buy
21,618
+3,418
+19% +$39.7K 0.19% 40
2022
Q3
$190K Sell
18,200
-12,951
-42% -$169K 0.2% 27
2022
Q2
$392K Buy
+31,151
New +$331K 0.32% 15

Other funds holding DVAX

New Vernon Capital Holdings II's DVAX Position: Q1 2024 in Review

New Vernon Capital Holdings II sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 1,601 shares — an estimated $22.4K sold.

New Vernon Capital Holdings II first reported a position in DVAX in Q2 2022 and held it in 7 quarters. The position peaked at $401K in Q3 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • New Vernon Capital Holdings II reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 1,601 Dynavax Technologies shares in Q1 2024, an estimated $22.4K.
  • New Vernon Capital Holdings II first reported a position in Dynavax Technologies in Q2 2022 and held it in 7 quarters.
  • New Vernon Capital Holdings II's Dynavax Technologies position peaked at $401K in Q3 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2024, filed 15 May 2024.